| Campton Discount Drugs | |
| 33 Main St, Ste 2, Campton, Kentucky 41301 | |
| (606) 668-3153 |
| Name | Campton Discount Drugs |
|---|---|
| Organization Name | Campton Pharmacare Inc |
| Location | 33 Main St, Ste 2, Campton, Kentucky 41301 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (606) 668-3153 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
Age issues emerge in the health care reform debate as lawmakers struggle with how much young and old people should pay for insurance. Meanwhile, lawmakers and different groups try to woo seniors.
A team led by researchers at UC Santa Cruz has developed chip-based technology for reliable detection of Ebola virus and other viral pathogens. The system uses direct optical detection of viral molecules and can be integrated into a simple, portable instrument for use in field situations where rapid, accurate detection of Ebola infections is needed to control outbreaks.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has received an offer for funding from a biotech-oriented investment group called BIOTECH Development Partners, LLC.
› Verified 1 days ago
| NPI Number | 1174546543 |
| Organization Name | CAMPTON PHARMACARE INC |
| Doing Business As | CAMPTON DISCOUNT DRUGS |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 33 Main St, Suite 2, Campton, KY 41301 |
| Phone Number | 606-668-3153 |
News Archive
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
Age issues emerge in the health care reform debate as lawmakers struggle with how much young and old people should pay for insurance. Meanwhile, lawmakers and different groups try to woo seniors.
A team led by researchers at UC Santa Cruz has developed chip-based technology for reliable detection of Ebola virus and other viral pathogens. The system uses direct optical detection of viral molecules and can be integrated into a simple, portable instrument for use in field situations where rapid, accurate detection of Ebola infections is needed to control outbreaks.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has received an offer for funding from a biotech-oriented investment group called BIOTECH Development Partners, LLC.
› Verified 1 days ago
| NPI Number | 1730232893 |
| Organization Name | CAMPTON PHARMACARE, INC. |
| Doing Business As | CAMPTON DISCOUNT DRUGS |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 33 Main St., Suite 2, Campton, KY 41301 |
| Phone Number | 606-668-3153 |
News Archive
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
Age issues emerge in the health care reform debate as lawmakers struggle with how much young and old people should pay for insurance. Meanwhile, lawmakers and different groups try to woo seniors.
A team led by researchers at UC Santa Cruz has developed chip-based technology for reliable detection of Ebola virus and other viral pathogens. The system uses direct optical detection of viral molecules and can be integrated into a simple, portable instrument for use in field situations where rapid, accurate detection of Ebola infections is needed to control outbreaks.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has received an offer for funding from a biotech-oriented investment group called BIOTECH Development Partners, LLC.
› Verified 1 days ago
News Archive
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
Age issues emerge in the health care reform debate as lawmakers struggle with how much young and old people should pay for insurance. Meanwhile, lawmakers and different groups try to woo seniors.
A team led by researchers at UC Santa Cruz has developed chip-based technology for reliable detection of Ebola virus and other viral pathogens. The system uses direct optical detection of viral molecules and can be integrated into a simple, portable instrument for use in field situations where rapid, accurate detection of Ebola infections is needed to control outbreaks.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has received an offer for funding from a biotech-oriented investment group called BIOTECH Development Partners, LLC.
› Verified 1 days ago
Campton Discount Drugs Type: Durable Medical Equipment & Medical Supplies Supplier Location: 33 Main St, Campton, Kentucky 41301 Phone: (606) 668-3153 | |
Wolfe Prescription Center Type: Durable Medical Equipment & Medical Supplies Supplier Location: 217 Mountain Parkway Spur, Campton, Kentucky 41301 Phone: (606) 668-3900 |